The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000448.3(RAG1):c.1A>G (p.Met1Val)

CA5949886

304491 (ClinVar)

Gene: RAG1
Condition: recombinase activating gene 1 deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: 2fc4f944-3174-4e9b-8f14-dd1c7dde76ac
Approved on: 2024-01-17
Published on: 2024-01-17

HGVS expressions

NM_000448.3:c.1A>G
NM_000448.3(RAG1):c.1A>G (p.Met1Val)
NC_000011.10:g.36573305A>G
CM000673.2:g.36573305A>G
NC_000011.9:g.36594855A>G
CM000673.1:g.36594855A>G
NC_000011.8:g.36551431A>G
NG_007528.1:g.10293A>G
ENST00000299440.6:c.1A>G
ENST00000299440.5:c.1A>G
ENST00000534663.1:c.1A>G
NM_000448.2:c.1A>G
NM_001377277.1:c.1A>G
NM_001377278.1:c.1A>G
NM_001377279.1:c.1A>G
NM_001377280.1:c.1A>G
More

Uncertain Significance

Met criteria codes 2
PM2_Supporting PVS1_Moderate
Not Met criteria codes 7
PS3 PP4 BA1 PM3 PM1 BS3 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RAG1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The NM_000448.3:c.1A>G (p.Met1Val) variant in RAG1 is an initiation codon variant that is not expected to result in nonsense-mediated mRNA decay but may cause a truncated protein by using an alternative start codon (Met183). There is one frameshift variant (p.K86VfsX33) that occurs upstream of codon 183, which causes the production of an N-terminally truncated RAG1 with low recombination activity and altered cellular localization (PMIDs 24290284, 11121059, 27301863) (PVS1_Moderate). The gnomAD 2.1.1 Popmax filtering allele frequency of this variant is 0.0001017, which is lower than the SCID VCEP threshold for PM2 (0.000102), and no homozygous individual has been observed in the gnomAD. Therefore it meets this criterion (PM2_Supporting). The variant has been detected in at least four individuals diagnosed with primary immunodeficiency. Patient A, reported by PMID 26186701, was heterozygous for this variant and a p.R737H variant (not curated by the SCID-VCEP), 0 pt. The other three individuals were reported in ClinVar entries without the information of the second allele, and in all three entries, the variant was classified as Uncertain Significance (Illumina Laboratory Services, SCV000371654.2; Illumina Laboratory Services, SCV000371655.2; Invitae, SCV001230493.3). The reported patient information is not sufficient to meet PM3 or PP4 criteria. Due to insufficient evidence, this variant is classified as a variant of uncertain significance for SCID based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID-VCEP: PVS1_Moderate, PM2_Supporting (SCID VCEP specifications version 1.0).
Met criteria codes
PM2_Supporting
The gnomAD 2.1.1 Popmax filtering allele frequency of this variant is 0.0001017, which is lower than the SCID VCEP threshold for PM2 (0.000102), and no homozygous individual has been observed in the gnomAD. Therefore it meets this criterion (PM2_Supporting).
PVS1_Moderate
The NM_000448.3(RAG1):c.1A>G (p.Met1Val) variant in RAG1 is not expected to result in nonsense-mediated mRNA decay but may cause a truncated protein by altering the start codon of the coding sequence. The next in-frame Met codon localizes at codon 183. There exists a frameshift variant (p.K86VfsX33) that occurs upstream of codon 183 and causes the initiation of translation from codon 183. This N-terminally truncated RAG1 shows low recombination activity and altered cellular localization, showing that the N-terminal sequence upstream of codon 183 is critical for the function of RAG1. (PMIDs 24290284, 11121059, 27301863). PVS1_Moderate.
Not Met criteria codes
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
One patient with this variant displayed phenotypes specific to primary immunodeficiency. However, the patient does not show a typical T-B-NK+ lymphocyte profile (0pt received). A genetic screen was performed, and no disease-causing mutations were identified in genes known to be responsible for predominantly antibody deficiency syndromes (PMID 26186701, patient A) (0.5pt received). TOTAL 0.5 pt, PP4 not applied.
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM3
This variant has been detected in at least four individuals with CID/SCID/Omenn Syndrome. One individual was compound heterozygous for the variant and a variant that has not been curated by the SCID-VCEP (p.R737H). The trans phase was not confirmed by testing the parents or the offsprings (PMID 26186701 patient A, 33193364 patient #3) 0 pts; the PM3 criterion is not met.
PM1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.